Anthony M. Musolf
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
RNA modifications and cancer, Ophthalmology and Visual Impairment Studies, Lung Cancer Treatments and Mutations, Genetic Associations and Epidemiology, Genetic factors in colorectal cancer
Most-Cited Works
- → REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants(2016)2,867 cited
- → What makes a good prediction? Feature importance and beginning to open the black box of machine learning in genetics(2021)120 cited
- → IMI 2021 Yearly Digest(2021)65 cited
- → Evaluation of Shared Genetic Susceptibility to High and Low Myopia and Hyperopia(2021)51 cited
- → Chromatin Profiling Reveals Regulatory Network Shifts and a Protective Role for Hepatocyte Nuclear Factor 4α during Colitis(2014)47 cited
- → Genome-wide association meta-analysis of corneal curvature identifies novel loci and shared genetic influences across axial length and refractive error(2020)41 cited
- → Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies(2017)41 cited
- → A new polygenic score for refractive error improves detection of children at risk of high myopia but not the prediction of those at risk of myopic macular degeneration(2023)28 cited
- → Joint multi-ancestry and admixed GWAS reveals the complex genetics behind human cranial vault shape(2023)23 cited
- → Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing(2019)21 cited